IESE (España)
-
Genmedi: How to Value a New Company for an Upcoming Round of Financing - Teaching Note
Liechtenstein, Heinrich; Kolarova, LenkaTeaching Note ET-34-EEntrepreneurship, FinanceEvery venture capital and private equity deal involves determining the value of the company. This is one of the most important-and most difficult-tasks faced by an investor (and an entrepreneur), and skill is required when using the various methods for valuing a company. In March 2019, the investors in LifeCycle Ltd.-a technology company based in Shanghai, China-set up a new company, Genmed, to capitalize on an innovative technology for biologica...Starting at €0.00
-
Visant Capital
Kelly, Peter; Liquido, Francisco; Liechtenstein, HeinrichCase E-168-EEntrepreneurshipDhruv is an Indian search fund entrepreneur. His is only the second search fund in India. More than a year into his search, he has finally found a company for acquisition and it is time to bring it to investors. Will they like the company? Or will he have to keep searching?Starting at €8.20
-
Teléfonos de México, S.A. de C.V. and the Prodigy Internet Plus decision
Lamyin, M.; Bertini, Marco; Nueno, José LuisCase M-1124-EInformation Technologies, MarketingThe case analyzes the strategy Telmex must follow in order to increase the customer base of its ISP service in Mexico. The low disposable income of the Mexican population and the inability to afford computers must be taken into account. The company must also consider its recent acquisition of Prodigy (one of the leading ISPs in the U.S.) and analyze the role it should play in the new marketing strategy.Starting at €8.20
-
Genmedi: How to Value a New Company for an Upcoming Round of Financing
Liechtenstein, Heinrich; Kolarova, LenkaCase E-207-EEntrepreneurship, FinanceEvery venture capital and private equity deal involves determining the value of the company. This is one of the most important-and most difficult-tasks faced by an investor (and an entrepreneur), and skill is required when using the various methods for valuing a company. In March 2019, the investors in LifeCycle Ltd.-a technology company based in Shanghai, China-set up a new company, Genmed, to capitalize on an innovative technology for biologica...Starting at €8.20